These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8551028)

  • 21. A peptide containing a novel FPGN CD40-binding sequence enhances adenoviral infection of murine and human dendritic cells.
    Richards JL; Abend JR; Miller ML; Chakraborty-Sett S; Dewhurst S; Whetter LE
    Eur J Biochem; 2003 May; 270(10):2287-94. PubMed ID: 12752448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CD40 ligand expressed by human B cells costimulates B cell responses.
    Grammer AC; Bergman MC; Miura Y; Fujita K; Davis LS; Lipsky PE
    J Immunol; 1995 May; 154(10):4996-5010. PubMed ID: 7537298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation.
    Lane P; Brocker T; Hubele S; Padovan E; Lanzavecchia A; McConnell F
    J Exp Med; 1993 Apr; 177(4):1209-13. PubMed ID: 7681469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
    Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
    J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes.
    Hermann P; Blanchard D; de Saint-Vis B; Fossiez F; Gaillard C; Vanbervliet B; Brière F; Banchereau J; Galizzi JP
    Eur J Immunol; 1993 Apr; 23(4):961-4. PubMed ID: 7681403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. System for cleavable Fc fusion proteins using tobacco etch virus (TEV) protease.
    Haspel J; Blanco C; Jacob J; Grumet M
    Biotechniques; 2001 Jan; 30(1):60-1, 64-6. PubMed ID: 11196321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-level expression of soluble protein in Escherichia coli using a His6-tag and maltose-binding-protein double-affinity fusion system.
    Pryor KD; Leiting B
    Protein Expr Purif; 1997 Aug; 10(3):309-19. PubMed ID: 9268677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and in vitro characterization of canine CD40-Ig.
    Jochum C; Beste M; Stone D; Graves SS; Storb R
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):260-5. PubMed ID: 18387675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble FasR ligand-binding domain: high-yield production of active fusion and non-fusion recombinant proteins using the baculovirus/insect cell system.
    Mahiou J; Abastado JP; Cabanie L; Godeau F
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):1051-8. PubMed ID: 9480929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homo-oligomer formation by basigin, an immunoglobulin superfamily member, via its N-terminal immunoglobulin domain.
    Yoshida S; Shibata M; Yamamoto S; Hagihara M; Asai N; Takahashi M; Mizutani S; Muramatsu T; Kadomatsu K
    Eur J Biochem; 2000 Jul; 267(14):4372-80. PubMed ID: 10880960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of germ-line gamma 1 and epsilon Ig gene expression in murine B cells. IL-4 and the CD40 ligand-CD40 interaction provide distinct but synergistic signals.
    Warren WD; Berton MT
    J Immunol; 1995 Dec; 155(12):5637-46. PubMed ID: 7499848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
    Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
    J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligation of CD40 influences the function of human Ig-secreting B cell hybridomas both positively and negatively.
    Bergman MC; Attrep JF; Grammer AC; Lipsky PE
    J Immunol; 1996 May; 156(9):3118-32. PubMed ID: 8617932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains.
    Cheon HG; LaRochelle WJ; Bottaro DP; Burgess WH; Aaronson SA
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):989-93. PubMed ID: 8302878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cytotoxic CD40/p55 tumor necrosis factor receptor hybrid detects CD40 ligand on herpesvirus saimiri-transformed T cells.
    Hess S; Kurrle R; Lauffer L; Riethmüller G; Engelmann H
    Eur J Immunol; 1995 Jan; 25(1):80-6. PubMed ID: 7531151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.
    Foy TM; Shepherd DM; Durie FH; Aruffo A; Ledbetter JA; Noelle RJ
    J Exp Med; 1993 Nov; 178(5):1567-75. PubMed ID: 7693850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural requirements for mucosal vascular addressin binding to its lymphocyte receptor alpha 4 beta 7. Common themes among integrin-Ig family interactions.
    Briskin MJ; Rott L; Butcher EC
    J Immunol; 1996 Jan; 156(2):719-26. PubMed ID: 8543825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD40 signalling in ileal Peyer's patch B cells: implications for T cell-dependent antigen selection.
    Griebel P; Ferrari G
    Int Immunol; 1995 Mar; 7(3):369-79. PubMed ID: 7540860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins.
    Schneider P
    Methods Enzymol; 2000; 322():325-45. PubMed ID: 10914028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors.
    Holler N; Kataoka T; Bodmer JL; Romero P; Romero J; Deperthes D; Engel J; Tschopp J; Schneider P
    J Immunol Methods; 2000 Apr; 237(1-2):159-73. PubMed ID: 10725460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.